Hyperpolarized 3He MR for Sensitive Imaging of Ventilation Function and Treatment Efficiency in Young Cystic Fibrosis Patients with Normal Lung Function

被引:66
|
作者
Bannier, Elise [1 ]
Cieslar, Katarzyna [1 ]
Mosbah, Karim [1 ]
Aubert, Francoise [2 ]
Duboeuf, Francois [1 ]
Salhi, Zahir [3 ]
Gaillard, Sophie [1 ]
Berthezene, Yves [1 ]
Cremillieux, Yannick [1 ]
Reix, Philippe [4 ]
机构
[1] Univ Lyon, CNRS, INSERM, CREATIS,UMR 5220,U630,LRMN, F-69622 Villeurbanne, France
[2] Ctr Invest Clin, Lyon, France
[3] Johannes Gutenberg Univ Mainz, Mainz, Germany
[4] Hop Femme Mere Enfant, Serv Pediat, Lyon, France
关键词
COMPUTED-TOMOGRAPHY; AIR SPACES; CHILDREN; SPIROMETRY; DISEASE; GAS;
D O I
10.1148/radiol.09090039
中图分类号
R8 [特种医学]; R445 [影像诊断学];
学科分类号
1002 ; 100207 ; 1009 ;
摘要
Purpose: To assess the sensitivity of hyperpolarized helium 3 (He-3) magnetic resonance (MR) imaging for the detection of peripheral airway obstruction in younger cystic fibrosis (CF) patients showing normal spirometric results (mean forced expiratory volume in 1 second [FEV1], 112% +/- 14.5 [standard deviation]) and to observe the immediate effects of a single chest physical therapy (CPT) session, thereby comparing two image quantification techniques. Materials and Methods: Ten pediatric CF patients (age range, 8-16 years) with normal spirometric results were included in this study after approval from the local research ethics committee. Spirometry followed by proton and hyperpolarized 3 He three-dimensional lung imaging were performed with a 1.5-T MR unit before and after 20 minutes of CPT. The number of ventilation defects per image (VDI) and the ventilated lung fraction (VF), defined as the ratio of ventilated lung volume divided by total lung volume, were quantified. Results: Ventilation defects were found in all patients (mean VDI, 5.1 +/- 1.9; mean global VF, 78.5% +/- 12.3; and mean peripheral VF, 75.5% +/- 17.1) despite normal spirometric results. After CPT, disparate changes in the distribution of ventilation defects were observed but the average VDI and VF did not change significantly (mean VDI, 5.1 +/- 1.1; mean global VF, 83.5% +/- 12.2; and mean peripheral VF, 80.3% +/- 12.2). There was no correlation between FEV1 and VDI (rho = -0.041, P = .863) or global VF (rho = -0.196, P = .408) values but peripheral VF and VDI were correlated (rho = -0.563, P = .011). Conclusion: Although spirometric results indicate normal lung function, the mean VDI in patients (5.1) found in this study is well above the VDI in healthy subjects (1.6) reported in the literature. A single CPT session induces disparate changes in the distribution and extent of ventilation defects. (C) RSNA, 2010
引用
收藏
页码:225 / 232
页数:8
相关论文
共 29 条
  • [21] Changes in Lung Function in Young Cystic Fibrosis Patients Between Two Courses of Intravenous Antibiotics Against Pseudomonas aeruginosa
    Beghin, Laurent
    Michaud, Laurent
    Loeuille, Guy-Andre
    Wizla-Derambure, Nathalie
    Sayah, Hocine
    Sardet, Anne
    Thumerelle, Caroline
    Deschildre, Antoine
    Turck, Dominique
    Gottrand, Frederic
    PEDIATRIC PULMONOLOGY, 2009, 44 (05) : 464 - 471
  • [22] Normalized T1 Magnetic Resonance Imaging for Assessment of Regional Lung Function in Adult Cystic Fibrosis Patients - A Cross-Sectional Study
    Dasenbrook, Elliott C.
    Lu, Lan
    Donnola, Shannon
    Weaver, David E.
    Gulani, Vikas
    Jakob, Peter M.
    Konstan, Michael W.
    Flask, Chris A.
    PLOS ONE, 2013, 8 (09):
  • [23] Changes in lung function measured by spirometry and the forced oscillation technique in cystic fibrosis patients undergoing treatment for respiratory tract exacerbation
    Ren, CL
    Brucker, JL
    Rovitelli, AK
    Bordeaux, KA
    PEDIATRIC PULMONOLOGY, 2006, 41 (04) : 345 - 349
  • [24] Human epididymis protein 4 (HE4) levels inversely correlate with lung function improvement (delta FEV1) in cystic fibrosis patients receiving ivacaftor treatment
    Nagy, Bela, Jr.
    Bene, Zsolt
    Fejes, Zsolt
    Heltshe, Sonya L.
    Reid, David
    Ronan, Nicola J.
    McCarthy, Yvonne
    Smith, Daniel
    Nagy, Attila
    Joseloff, Elizabeth
    Balla, Gyorgy
    Kappelmayer, Janos
    Macek, Milan, Jr.
    Bell, Scott C.
    Plant, Barry J.
    Amaral, Margarida D.
    Balogh, Istvan
    JOURNAL OF CYSTIC FIBROSIS, 2019, 18 (02) : 271 - 277
  • [25] Pilot study of paediatric regional lung function assessment via X-ray velocimetry (XV) imaging in children with normal lungs and in children with cystic fibrosis
    Bruorton, Matthew
    Donnelley, Martin
    Goddard, Thomas
    O'Connor, Antonia
    Parsons, David
    Phillips, Jessica
    Carson-Chahhoud, Kristin
    Tai, Andrew
    BMJ OPEN, 2024, 14 (02):
  • [26] Short-Term Effect of Different Physical Exercises and Physiotherapy Combinations on Sputum Expectoration, Oxygen Saturation, and Lung Function in Young Patients with Cystic Fibrosis
    Kriemler, Susi
    Radtke, Thomas
    Christen, Gregor
    Kerstan-Huber, Marta
    Hebestreit, Helge
    LUNG, 2016, 194 (04) : 659 - 664
  • [27] Improvement in exercise duration, lung function and well-being in G551D-cystic fibrosis patients: a double-blind, placebo-controlled, randomized, cross-over study with ivacaftor treatment
    Edgeworth, Deirdre
    Keating, Dominic
    Ellis, Matthew
    Button, Brenda
    Williams, Elyssa
    Clark, Denise
    Tierney, Audrey
    Heritier, Stephane
    Kotsimbos, Tom
    Wilson, John
    CLINICAL SCIENCE, 2017, 131 (15) : 2037 - 2045
  • [28] Lung Function in Patients with Cystic Fibrosis before and during CFTR-Modulator Therapy Using 3D Ultrashort Echo Time MRI
    Heidenreich, Julius Frederik
    Kuhl, Philipp Josef
    Grunz, Jan-Peter
    Hendel, Robin
    Metz, Corona
    Weng, Andreas Max
    Benkert, Thomas
    Hebestreit, Helge
    Bley, Thorsten Alexander
    Kostler, Herbert
    Veldhoen, Simon
    RADIOLOGY, 2023, 308 (01)
  • [29] Low-dose insulin therapy in patients with cystic fibrosis and early-stage insulinopenia prevents deterioration of lung function: a 3-year prospective study
    Kolouskova, Stanislava
    Zemkova, Daniela
    Bartosova, Jana
    Skalicka, Veronika
    JOURNAL OF PEDIATRIC ENDOCRINOLOGY & METABOLISM, 2011, 24 (7-8): : 449 - 454